Liki24, an online medication ordering platform operating in Italy, Germany, Ukraine, Romania, France, Austria, the Netherlands, Belgium, and Spain, plans to use the newly raised capital to expand into additional European markets and further enhance its digital infrastructure.
In 2024, the company doubled its growth rate within the EU, with European markets now accounting for 60% of total company revenue.
According to Viktoriya Tigipko, founder and managing partner of TA Ventures, Liki24.com is well-positioned to become a leading health goods marketplace for millions of Europeans, backed by its strong growth trajectory, solid partnerships, and scalable business model.
To date, Liki24 has served more than 2.5 million users. Its website and mobile apps attract over 3 million monthly visitors, and the platform features over 13,000 active sellers.
Founded in 2017 by Anton Avrinsky, Dmytro Lyatambur, Serhii Fadeiev, Serhii Klebanov, and Volodymyr Zubenko, the startup had previously raised around $6 million in funding prior to this latest round.
